• The MetaHeps® test is the first in vitro test for diagnosis or exclusion of drug-induced liver injury (DILI) in individual patients
  • Major application fields are clinical drug development and pharmacovigilance
  • In case of DILI suspicion the MetaHeps services will discriminate DILI from other causes of liver injury
  • When DILI is confirmed, the MetaHeps® test will support causality assessment even in polymedication